Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
0
BY KAVITA IYER ON DECEMBER 9, 2015
HTTP://WWW.TECHWORM.NET/2015/12/FDA-CLEARS-XSTAT-GUNSHOT-WOUNDDRESSING.HTML
Originally developed for the military, the FDA says first responders can now use XStat 30 to treat
adolescents and adults in the civilian population who are facing life-threatening and severe hemorrhagic
shock.
It is very important to control severe bleeding very early. XStat 30 could help to further that trend once
its in civilian use. About 30% to 40% of traumatic injury deaths of U.S. civilians are a result of
hemorrhaging, according to the United States Army Institute of Surgical Research. Of these, 33% to
56% occurred before the patient reached the hospital.
When a product is developed for use in the battlefield, it is generally intended to work in a worst-case
scenario where advanced care might not be immediately available, said Dr. William Maisel in a FDA
release. It is exciting to see this technology transition to help civilian first responders control some
severe, life-threatening bleeding while on the trauma scene.
The FDA has specifically cleared that XStat 30 should be used only in patients at high risk for
immediate, life-threatening and severe hemorrhagic shock and noncompressible junctional wounds,
when definitive care at an emergency care facility cannot be reached within minutes, and not to be used
in certain parts of the chest, abdomen, pelvis, or tissue above the collarbone.
About 33,000 people are killed by the guns in the United States annually, of which some 20,000 are
suicides and 11,000 are homicides. The United States this yes alone has experiences 462 mass
shootings. So, the announcement of XStat 30s approval comes at a time when they seem to be needed
the most.